European Psychiatry - Volume 41 - April 2017

816 / 916

S812 25th European Congress of Psychiatry / European Psychiatry 41S (2017) S772–S846
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV1244
Psychosis and psoriasis, the skin talks
the truth
S. Garcia Marin ∗ . De Haro García Martínez Pedrosa
M.D. Ortega García arti Garnica
1 Centro Salud Mental Lorca, Adultos, Lorca, Spain
2 Centro Salud Mental Lorca, CAD, Lorca, Spain
3 Hospital de Vinalopó, Adultos, Elche, Spain
4 Centro de Salud Mental Cartagena, Infantil, Cartagena, Spain
5 Centro de Salud Mental Cartagena, Adultos, Cartagena, Spain
∗ Corresponding author.
Introduction It is well known about relation between skin and
mind, not only due to their mutual origin, but also by their illness
expression parallelism. We report a case to show that reciprocity.
Personal antecedents Woman, 42-year-old, single. She only suf-
fers from a skin disease; mild psoriasis guttata placed in both
elbows and knees. She treated it with local treatment (cortisone
cream) during seasonal prutius and the lesions did not grow or
expand. Shewas hospitalized due to psychotic symptoms (paranoid
delusions with her colleagues) and started antipsychotics treat-
ment (risperidone 12mg per day and olanzapine 10mg per night).
By the same time, she suffered a psoriasis crisis. Her psoriatic
plaques increased their sizes and her chest and both thighs were
affected too. She complained about grave pruritus. All her medi-
cal test results were normal. After that, the patient improved her
psychotics’ symptoms, but she started with agoraphobic signs and
seclusion at home. Psoriasis were even worse than before and she
needed metrotexate to treat it. Being introduced to escitalopram
15mg per day, anxiety and depression symptoms disappeared and
her grave psoriasis became the mild one that she knew.
Conclusion Schizophrenia was associated with a greater variety
of autoimmune diseases than was anticipated. Studies found evi-
dence for a shared genetic etiology between schizophrenia and
psoriasis. Despite that, we think that the study of psychopathol-
ogy can amplify our understanding about the etiopathogenesis of
psoriasis and associated mental disorders.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV1245
Frontotemporal dementia
misdiagnosed as schizophrenia or
other psychotic disorder
A. Giamarelou , P. Polychronopoulos , M. Skokou ∗,
L. Messinis , P. Gourzis
1 University Hospital of Patra, Rio, Greece
2 Department of Psychiatry, University of Patra, Patra, Greece
3 Department of Neyrology, University of Patras, Patra, Greece
∗ Corresponding author.
Introduction Frontotemporal dementia (FTD) encompasses a
group of clinical features that include personality and behav-
ior changes (disinhibition, social isolation, antisocial behavior,
compulsion) and executive dysfunction (poor planning, loss of
judgment and loss of insight). These features may lead to an incor-
rect diagnosis of a primary psychiatric disorder.
Objectives To emphasize the difficulties in making a clinical
distinction between early frontotemporal dementia and other psy-
chiatric diseases.
Methods We describe 11 patients who suffered from FTD, while
initially had diagnosedwith primary psychiatric disorders. The cor-
rect diagnosis was achieved by psychiatric and neuropsychological
evaluations (WAIS SCALE, ACE-R, MMSE), neuroimaging studies
(MRI 7/11, SPECT 8/11) and applying the international consensus
criteria for FTD.
Results All patients (5 males and 6 females) were initially diag-
nosed with psychiatric disorders: schizophrenia (2/11), bipolar
disorders (4/11), depression (5/11), schizoaffective disorder (1/11),
somatization disorder (1/11), personality disorders (2/11), malin-
gering (1/11), alcohol dependence (1/11), while 5patients hadmore
than one diagnosis. The age of onset varied from 19 to 53 years old.
Final diagnosis of FTD was delayed on average 6,5 years from the
onset of symptoms.
Conclusion Clinicians should be familiar with the clinical entity
of FTD and its difficult distinction from other psychiatric disorders.
A possible hospitalization of a patient with FTD in a psychiatric
department and the social impact that it brings may be avoided. On
the other hand, the proper care of FTD patients (pharmacological
and psychosocial) improves the quality of life of patients and their
caregivers.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV1246
Validation of the Portuguese version
of the consumer experiences of
stigma questionnaire (CESQ)
L. Mendonc¸ a , S. Azeredo-Lopes , I. Landeiro , J. Grácio ,
M. Gonc¸ alves-Pereira ∗
1 Hospital de Cascais, Departamento de Saúde Mental, Cascais,
Portugal
2 Nova Medical School/Faculdade de Ciências Médicas, Universidade
Nova de Lisboa, Department of Biostatistics and Informatics, Lisbon,
Portugal
3 CHLO, Centro Hospitalar de Lisboa Ocidental, Psychiatry and Mental
Health, Lisbon, Portugal
4 Nova Medical School/Faculdade de Ciências Médicas, Universidade
Nova de Lisboa, CEDOC, Chronic Diseases Research Center, Lisbon,
Portugal
∗ Corresponding author.
Introduction Tackling stigma and discrimination is a major con-
cern worldwide as demonstrated e.g. in the European Mental
Health Action Plan. We need valid and feasible indicators to assess
the stigma of mental illness. In Portugal, validated scales focused
on mental health consumers’ personal experiences of stigma are
scarce. The consumer experiences of stigma questionnaire (CESQ)
(Wahl, 1999), developed in collaborationwith the National Alliance
for the Mentally Ill, focuses on users’ real life experiences. Although
it was validated in different countries, some psychometric proper-
ties (e.g. test-retest reliability) are to be tested.
Objectives To further assess CESQ psychometric properties and
to validate its Portuguese translation.
Methods The CESQ Portuguese translation was developed in col-
laboration with the author (Otto Wahl), using standard translation
and back-translation procedures. The acceptability of items was
assessed in pilot studies and discussed in groups also involving
health professionals. The measure was then used in a convenience
sample of 122 persons with severe mental illness. Assessments
included test-retest reliability ( n = 48). A factor analysis was also
conducted.
Results Overall, the CESQ translation proved acceptable and
missing items were few, not compromising the analysis. The intra-
class correlation coefficient (ICC) for test-retest reliability was 0.83
[95% CI 0.71–0.90] and Cronbach’s alpha for internal consistency
was 0.80 [95% CI 0.75–0.85]. In the principal component analy-
sis, factor loadings confirmed the two originally reported domains:
stigma and discrimination.